References
- Bieber L. L. Carnitine. Annual Review of Biochemistry 1988; 57: 261–283
- Bieber L. L., Emaus R., Valker K., Farrell S. Possible functions of short-chain and medium-chain carnitine actyl-transferases. Federation Proceedings 1982; 41: 2858–2862
- Binderup E., Godtfredsen W. O., Roholt J. Orally active cephaloglycin esters. Journal of Antibiotics 1971; 24: 767–773
- Bohles H., Lehnert W. The effect of intravenous L-carnitine on propionic acid excretion in acute propionic acidemia. European Journal of Pediatrics 1984; 143: 61–63
- Bremer J. Carnitine-metabolism and functions. Physiological Reviews 1983; 63: 1440–1480
- Di Donato S., Rimoldi M., Garavaglia B., Uziel G. Propionyl carnitine excretion in propionic and methylmalonic acidurias: a cause of carnitine deficiency. Clinica Chimica Acta 1984; 139: 13–21
- Editorial., Carnitine deficiency. Lancet 1990; 1: 631–633
- Gatzola-Karavelli M., Vogiatzis N., Rousso I., Sklavuno-Tsurutsoglu S., Germano G., Kissling M. Cefetamet piroxil in pediatric patients suffering from lower respiratory tract infections. Pharmatherapeutica 1989; 5: 423–428
- Haeckel R. Assay of creatinine in serum with use of Fuller's earth to remove interferents. Clinical Chemistry 1981; 27: 179–183
- Harper P., Elvin C. E., Cederblad G. Pharmacokinetics of bolus intravenous and oral doses of L-carnitine in healthy subjects. European Journal of Clinical Pharmacology 1988; 35: 69–75
- Holme E., Greter J., Jacobson C. E., Lindstedt S., Nordin I., Kristiansson B., Jodal U. Carnitine deficiency induced by pivampicillin and pivmecillinam therapy. Lancet 1989; ii: 469–472
- Kerner J., Froseth J. A., Miller E. R., Bieber L. L. A study of the acylcarnitine content of sows' colostrum, milk and newborn adipose tissues: demonstration of high amounts of isovaleryl-carnitine in colostrum and milk. Journal of Nutrition 1984; 114: 854–861
- Kissling M., Germano G., Fernex M. Cefetamet pivoxil, a new oral cephalosporin: clinical evaluation. Chemotherapy 1988; 34: 519–529
- Melegh B. Carnitine supplementation in pivampicillin treatment. Lancet 1989; ii: 1096
- Melegh B., Jaszai V. Carnitine content of red blood cells of human subjects treated with pivampicillin and carnitine. Acta Paediatrica Hungarica 1991; 31: 255–261
- Melegh B., Kerner J., Bieber L. L. Pivampicillin-promoted excretion of pivaloylcarnitine in humans. Biochemical Pharmacology 1987; 36: 3405–3409
- Melegh B., Kerner J., Jaszai V., Bieber L. L. Differential excretion of xenobiotic acyl esters of carnitine due to administration of pivampicillin and valproate. Biochemical Medicine and Metabolic Biology 1990; 43: 30–38
- Melegh B., Szucs L., Kerner J., Sandor A. Changes of plasma free amino acids and renal clearances of carnitines in premature infants during L-carnitine supplemented human milk feeding. Journal of Pediatric Gastroenterology and Nutrition 1988; 7: 424–429
- Rebouche C. J., Mack D. L., Edmonson P. F. L-Carnitine dissimilation in the gastrointestinal tract of the rat. Biochemistry 1984; 23: 6422–6426
- Roe C. R., Millington D. S., Maltby D. A., Bohan T. P., Kahler S. G., Chalmers R. A. Diagnostic and therapeutic implications of medium-chain acylcarnitines in the medium-chain acyl-CoA dehydrogenase deficiency. Pediatric Research 1985; 19: 459–466
- Ruff L. J., Brass E. P. Metabolic effects of pivalate in isolated rat hepatocytes. Toxicology and Applied Pharmacology 1991; 110: 295–302
- Stumpf D. A., Parker W. D., Angelini C. Carnitine deficiency, organic acidemias, and Reye's syndrome. Neurology 1985; 35: 1041–1045
- Vickers S., Duncan C. A. H., White S. D., Ramjit H. G., Smith J. L., Walker R. W., Flynn H., Arison B. H. Carnitine and glucuronic acid conjugates of pivalic acid. Xenobiotica 1985; 15: 453–458